Tela Bio

TELA Micro Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

$0.60

+5.01% today

52W: $0.50 – $2.20

52W Low: $0.50 Position: 5.7% 52W High: $2.20

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

—

Forward Price/Earnings

P/S Ratio

0.33x

Price-to-Sales

EV/EBITDA

—

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$26.7M

Market Capitalization

Revenue Growth

18.2%

YoY Revenue Growth

Profit Margin

-48.37%

Net profit margin

ROE

-223.35%

Return on Equity

Beta

0.99

Market sensitivity

Short Interest

1.6%

% of float sold short

Avg. Volume

192,483

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

5 analysts

Avg. Price Target

$2.25

+276.7% upside

Target Range

$1.00 – $3.25

About the Company

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United State

Sector: Healthcare Industry: Medical Devices Country: United States Exchange: NGM